EFFECT OF PLATELET-RICH PLASMA ON CHRONIC ODONTOGENIC MAXILLARY SINUS-ITIS: A PILOT STUDY

Introduction
CMOS is an inflammation of the maxillary sinus caused by dental infection. Patients with chronic periodontitis have an increased risk of developing maxillary sinusitis caused by intra-antral foreign bodies or by oroantral fistulas after tooth extraction [1, 2] . According to the literature in the field, the incidence of this disease in the adult population is 10-12%, but according to the latest studies, the incidence increased to 41% [3] [4] [5] . So far, there is no gold standard in choosing the most suitable treatment method for this inflammatory process. Until now, specialized literature suggests 3 main clinical methods to treat CMOS: the Caldwell-Luc operation, functional endoscopic sinus surgery and finally dental extraction or dental treatment. Using these surgical methods presents several disadvantages: bleeding, infraorbital nerve damage, facial swelling, pain, and significant hemorrhage may appear. These treatment methods require patient hospitalization and general anesthesia with possible complications [6, 7] . Platelet-rich-plasma (PRP) is a natural source of growth factors being considered an endogenous therapeutic technology used in many medical fields. PRP has the potential to stimulate and accelerate the healing process [8, 9, 14] . The main aim of this pilot study was to observe the effects of PRPrelated growth factors in patients diagnosed with CMOS.
Materials and Methods
The pilot study included five patients (4 men and 1 woman aged 40-64) diagnosed with CMOS following a dental exam and computer tomography (CT) (Fig.1) . PRP was obtained by venous blood collection in tubes containing separating gel with an inert polymer necessary to ensure the separation between erythrocytes and platelers. Sodium citrate was used as anticoagulant to prevent the initiation of the coagulation cascade. The samples were centrifuged at 4000 rpm for 5 minutes. Using the trepanation technique, inflammatory sinus mucosa was collected from the maxillary sinus in sterile tubes and was incubated with PRP for 7 days. PRP was injected in the inflammatory maxillary sinus PRP was injected in all patients based on a clinical chart. Along with the clinical study, lab study was conducted in order to underline the PRP procedure on the mucus, to prove the effect of growth factors implied in the local healing process. The control samples were represented by the inflammatory mucosa that were not treated with PRP and were collected in sterile tubes containing phosphate-buffered aline solution (pH 7.2). The samples were sonicated on ice (10 min, Sonoplus HD 2070, BANDELIN electronic GmbH & Co. KG, Berlin, Germany) and the lysate was stored at -80°C. All patients signed an informed consent and agreed to participate in the study. Insulin receptor (IR), insulin-like growth factor 1 receptor (IGF-1R) glycogen synthase kinase 3 beta (GSK3β) and glycogen synthase kinase 3 alfa (GSK3α) were detected using Luminex technology and Magnetic Bead-Based Multiplex assays (Akt/mTOR, Total protein 11-plex Magnetic Bead kit, 96 well plate, 48-612 MAG). This method can detect all the mentioned biomarkers from the same sample.
Statistical analysis
The statistical analysis was performed using student t-test and p-value less then 0.05 was considered statistically significant.
Results
The results of our study reveled statistically increased levels of IR, IGF-1, GSK3β and GSK3α for mucosa samples treated with PRP compared with mucosa a b
Original Articles Table 1 . Mean values for all four parameters detected. Table 1 and Fig. 2 .
Discussions
PRP is currently used in many medical fields such as orthopedic, pediatric, maxillofacial and plastic surgery, sport medicine, and cosmetic and dental implant surgery [9] [10] [11] [12] [13] . FDA (Food and Drug Administration) has classified PRP as a minimally manipulated tissue and an autologous blood product with multiple benefits for patients [14] . 
Conclusions
In conclusion, the growth factors released from platelets should be regarded as a positive effect source in the case of patients diagnosed with CMOS. These growth factors should activate the oligopotent stem cells which will finally lead to sinus mucosa regeneration. Future studies are needed to understand the molecular mechanisms that occur at the sinus level.
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